Professor | Wenbing Dai | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Wenbing Dai
Contact Information	daiwb@bjmu.edu.cn
Language ability	Chinese, English
Province	Beijing

Upload Avatar (500 x 500)

Name

Wenbing Dai

Contact Information

daiwb@bjmu.edu.cn

Language ability

Chinese, English

Province

Beijing

University/Lab Affiliation and Title	Peking University
Faculty	Pharmaceutical Sciences
Academic Background & Achievements	2006.09-2009.07 PhD: Peking University School of Pharmaceutical Sciences 2003.09-2006.07 Master's: Wuhan University School of Pharmaceutical Sciences 1999.09-2003.07 Bachelor's: Wuhan University School of Pharmaceutical Sciences H-index of 36 Obtained clinical approvals for 2 improved new drugs Received 1 National Science and Technology Progress Award (Second Prize) Received 1 Ministry of Education Natural Science Award (First Prize)
Work Experience	2018.08 - Present: Peking University School of Pharmaceutical Sciences - Associate Professor 2017.09 - 2018.10: Johns Hopkins University - Visiting Scholar 2012.08 - 2018.07: Peking University School of Pharmaceutical Sciences - Assistant Researcher
Awards	National Science and Technology Progress Award (Second Prize): Detail Ministry of Education Natural Science Award (First Prize): Detail

University/Lab Affiliation and Title

Peking University

Faculty

Pharmaceutical Sciences

Academic Background & Achievements

2006.09-2009.07 PhD: Peking University School of Pharmaceutical Sciences
2003.09-2006.07 Master's: Wuhan University School of Pharmaceutical Sciences
1999.09-2003.07 Bachelor's: Wuhan University School of Pharmaceutical Sciences
H-index of 36
Obtained clinical approvals for 2 improved new drugs
Received 1 National Science and Technology Progress Award (Second Prize)
Received 1 Ministry of Education Natural Science Award (First Prize)

Work Experience

2018.08 - Present: Peking University School of Pharmaceutical Sciences - Associate Professor
2017.09 - 2018.10: Johns Hopkins University - Visiting Scholar
2012.08 - 2018.07: Peking University School of Pharmaceutical Sciences - Assistant Researcher

Awards

National Science and Technology Progress Award (Second Prize): Detail
Ministry of Education Natural Science Award (First Prize): Detail

Areas of Focus	Peptide-based self-assembly drug delivery Antibody drug delivery New strategies and translational research for drug nanonization
Publications	An enzyme-responsive and transformable PD-L1 blocking peptide-photosensitizer conjugate enables efficient photothermal immunotherapy for breast cancer, Yanan Sun, Bochen Lyu, Chang Yang, Bing He, Hua Zhang, Xueqing Wang, Qiang Zhang, Wenbing Dai, 2023 Strengthened Tumor Photodynamic Therapy Based on a Visible Nanoscale Covalent Organic Polymer Engineered by Microwave Assisted Synthesis, Yao Lu, Ge Song, Bing He, Hua Zhang, Xueqing Wang, Demin Zhou, Wenbing Dai, Qiang Zhang, 2020 A combined “eat me/don’t eat me” strategy based on extracellular vesicles for anticancer nanomedicines, Zakia Belhadj, Bing He, Hailiang Deng, Siyang Song, Hua Zhang, Xueqing Wang, Wenbing Dai, Qiang Zhang, 2020 Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system, Binlong Chen, Wenbing Dai, Dong Mei, Tongzhou Liu, Suxin Li, Bo He, Bing He, Lan Yuan, Hua Zhang, Xueqing Wang, Qiang Zhang, 2016 Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer, Wenbing Dai, Fang Yang, Ling Ma, Yuchen Fan, Bing He, Qihua He, Xueqing Wang, Hua Zhang, Qiang Zhang, 2014

Areas of Focus

Peptide-based self-assembly drug delivery
Antibody drug delivery
New strategies and translational research for drug nanonization

Publications

An enzyme-responsive and transformable PD-L1 blocking peptide-photosensitizer conjugate enables efficient photothermal immunotherapy for breast cancer, Yanan Sun, Bochen Lyu, Chang Yang, Bing He, Hua Zhang, Xueqing Wang, Qiang Zhang, Wenbing Dai, 2023
Strengthened Tumor Photodynamic Therapy Based on a Visible Nanoscale Covalent Organic Polymer Engineered by Microwave Assisted Synthesis, Yao Lu, Ge Song, Bing He, Hua Zhang, Xueqing Wang, Demin Zhou, Wenbing Dai, Qiang Zhang, 2020
A combined “eat me/don’t eat me” strategy based on extracellular vesicles for anticancer nanomedicines, Zakia Belhadj, Bing He, Hailiang Deng, Siyang Song, Hua Zhang, Xueqing Wang, Wenbing Dai, Qiang Zhang, 2020
Comprehensively priming the tumor microenvironment by cancer-associated fibroblast-targeted liposomes for combined therapy with cancer cell-targeted chemotherapeutic drug delivery system, Binlong Chen, Wenbing Dai, Dong Mei, Tongzhou Liu, Suxin Li, Bo He, Bing He, Lan Yuan, Hua Zhang, Xueqing Wang, Qiang Zhang, 2016
Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer, Wenbing Dai, Fang Yang, Ling Ma, Yuchen Fan, Bing He, Qihua He, Xueqing Wang, Hua Zhang, Qiang Zhang, 2014

Peptide Self-Assembly Drug Delivery Antibody Nanomedicine Translational Research Cancer Therapy Nanotechnology Pharmaceutical Sciences Biomedical Engineering

Jun Qian - Fudan University

Hongjun Li - Zhejiang University

Yuqi Zhang - Zhejiang University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us